diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
Many people assume that “higher generations” of IVF mean more advanced technology, but clinicians prioritize indications and risk-benefit ratios. This article explains what first-, second-, and third-generation IVF mean in accessible yet medically rigorous terms, outlining target populations, key technologies, and complete procedures to help you reduce misinformation and decision anxiety.

I. Definition: “Generations” Refer to “Different Technical Combinations,” Not ‘Hierarchies’
In popular discourse, “first/second/third generation IVF” is a simplified term for communication. However, medical and international guidelines typically use specific technical names:
IVF (Conventional In Vitro Fertilization): Sperm and egg “naturally combine” in a petri dish to achieve fertilization.
ICSI (Intracytoplasmic Sperm Injection): An embryologist injects a single sperm into the egg to achieve fertilization. ASRM has provided systematic discussion on ICSI indications, emphasizing it is not routinely required for all patients.
PGT (Preimplantation Genetic Testing): Genetic testing performed before embryo transfer, commonly including:
PGT-A (Aneuploidy Screening, targeting risks of chromosomal number abnormalities)
PGT-M (Monogenic Disorders)
PGT-SR (Chromosomal Structural Rearrangements)
ACOG provides clear, accessible definitions of PGT's fundamental concepts and types.
Key Clarification: Clinically, “second generation” typically refers to switching to ICSI for fertilization; “third generation” usually denotes adding PGT testing at the embryo stage. They address different issues and do not inherently mean “better suited for you.”
II. Target Populations: Which scenarios are they respectively more suitable for?
Much confusion stems from a misconception: treating “generation” as a “success rate switch.” A more medically logical approach is to identify your core fertility barrier.
1) Scenarios more commonly termed “First Generation (IVF)”
Suitable for:
- Tubal factors (e.g., blockage, removal) preventing natural fertilization
- Ovulation disorders, endometriosis-related infertility (requires comprehensive evaluation)
Mild to moderate male factor infertility or unexplained infertility (specific decisions still depend on semen parameters and previous fertilization outcomes)
2) More commonly referred to as “second-generation (ICSI)” scenarios
ICSI functions more like a “fertilization fuse” and is more frequently considered in the following situations:
Clear male factor: Severe abnormalities in sperm count/motility/morphology
Previous conventional IVF resulted in fertilization failure or very low fertilization rates
When PGT is required, some centers may use ICSI to reduce risk of sperm contamination (specific practices vary by lab protocols)
The ASRM Committee explicitly discusses multiple indications for ICSI and cautions: Routine use in non-male factor cases requires careful evaluation.
3) More commonly referred to as “third-generation (PGT)” scenarios
These are more oriented toward “reducing specific genetic/chromosomal risks or optimizing pathways,” with common considerations including:
Known carrier status of a pathogenic variant for a monogenic disorder in one partner (PGT-M)
Structural chromosomal abnormalities such as balanced translocations or inversions in one partner (PGT-SR)
In cases of advanced maternal age, recurrent miscarriage, or repeated implantation failure, physicians may discuss the potential value and limitations of PGT-A (suitability requires individualized assessment).
The ASRM Committee Opinion on PGT-A states: PGT-A has not demonstrated consistent improvement in outcomes across all populations, and laboratory variability and methodological limitations exist.
Expert note: **PGT-A is screening, not a “guarantee.” It provides chromosomal information about embryos but offers uncertain predictions about live birth outcomes. Since sampling cells come from the trophoblast layer, results may not fully reflect the entire embryo. Interpretation and transfer strategies must follow institutional protocols.
III. Technology: What Additional Steps Are Involved in First, Second, and Third Generation PGT? How to Balance Risks and Benefits?
To help you develop a structured understanding, the following table outlines key differences (Note: Terminology and pathways may vary slightly by country/center).
Common Term Medical Term Key Addition Primary Issue Addressed Potential Drawbacks/Limitations
First Generation IVF (Conventional In Vitro Fertilization) Allows natural fertilization of egg and sperm in vitro Addresses “encounter difficulties” and partial fertilization issues Fertilization more heavily influenced by sperm function; rare fertilization failures may occur
Second Generation ICSI Micromanipulation: Injecting a single sperm into the egg Significant male factors, previous fertilization failures, etc. Adds micromanipulation step; controversy and need for assessment regarding “routine use for non-male factors”
Third Generation PGT (PGT-A/M/SR) Embryo biopsy + genetic testing Reduces specific genetic/chromosomal risks or aids embryo selection for transfer Higher costs and longer cycles; testing errors, mosaicism, and lab variability; does not improve outcomes for all populations
IV. Q&A: Clarifying Common Misconceptions
Q1: Is PGT-A necessarily “more advanced and successful” than ICSI or PGT-A?
Not necessarily. **“Advanced” does not equate to “suitable.” Third-generation adds genetic testing, primarily targeting reduced genetic/chromosomal risks or optimized embryo selection. However, it does not guarantee higher live birth rates for everyone. ASRM's guidance on PGT-A explicitly states: Consistent benefits are not observed across all populations.
Confidence Level: High (Based on authoritative society opinions and clinical consensus)
Q2: Should I undergo third-generation testing even without a family history of genetic disorders?
This falls under the decision of “whether to add supplementary testing,” typically weighing: female age, history of miscarriages/failed cycles, available embryo quantity, laboratory capabilities, budget, and time commitment. Without clear medical indications, doctors often emphasize individualized approaches over a “one-size-fits-all” solution.
Confidence Level: Moderate (High individual variation; requires consideration of medical history and testing)
Q3: Does ICSI “damage eggs” or “harm the child's health”?
ICSI is a mature micro-fertilization technique with long-term global application. However, it remains an additional procedure not required for all cases. Its use is typically based on fertilization risk assessment (e.g., male factors or previous fertilization failure). ASRM also notes that ICSI use for non-male factors requires careful consideration.
Confidence Level: Moderate (Overall safety accepted, but “necessity” requires individualized assessment)
Q4: How to interpret IVF success rates without being “misled by numbers”?
It's more advisable to examine three types of metrics:
Live birth/pregnancy outcomes within the same age group and diagnostic population (rather than lumping all individuals together)
Whether statistics are calculated per single transfer or **cumulatively (multiple transfers/cumulative live births)**
Whether data originates from official or academic disclosures
e.g., CDC provides official U.S. ART summaries and facility lookup tools to understand statistical definitions and annual variations.
Expert tip: When encountering “success rates,” first clarify four points: age stratification, diagnosis stratification, statistical scope (per transfer/per cycle/cumulative), and inclusion of frozen embryo transfers. Without these four variables, comparability is severely limited.
V. Process: Align “Generations” on a Single Timeline to Identify Differences
Regardless of generation (I, II, III), core processes are highly similar. Differences primarily lie in “fertilization method” and “PGT implementation.”
Initial Evaluation:
Ovarian reserve (AMH/AFC), semen analysis, uterine and tubal assessment, infectious disease screening, and baseline endocrine function.
Ovulation Induction and Monitoring:
Medication to stimulate multiple follicular development + ultrasound/hormone monitoring. International guidelines emphasize individualized protocols and OHSS risk management.
Oocyte Retrieval (typically ultrasound-guided) + Sperm Collection
Fertilization:
First Generation: Conventional IVF fertilization
Second Generation: ICSI fertilization (intracytoplasmic sperm injection)
Embryo Culture: D3 embryos or extended culture to blastocysts (D5/6, etc.)
(Third Generation Specific) Embryo Biopsy + PGT Testing: Typically requires cryopreservation pending results
Embryo Transfer: Fresh or frozen embryo transfer (determined by endometrial readiness, OHSS risk, PGT scheduling, etc.)
Luteal Support & Pregnancy Testing: Blood hCG, follow-up ultrasound monitoring
Expert Note: If proceeding with “third-generation” protocols, a common schedule adjustment involves “freezing embryos first, transferring later”—this is not failure or delay, but a necessary procedural step (waiting for testing results and optimizing the transfer window).
VI. Summary Box: Key Takeaways + How to Make Choices
Summary Box
What do first-, second-, and third-generation IVF mean? It's more like “abbreviations for technology combinations”:
- First-gen = Conventional IVF fertilization
- Second-gen = ICSI fertilization
- Third-gen = Adding PGT genetic testing before transfer
The selection logic isn't “higher is better,” but rather: what is your primary fertility challenge? Is there a clear indication? And do the risks/costs align with your goals?
PGT-related procedures (especially PGT-A) are “information-gaining tools” with varying benefits across different populations. ICSI isn't universally required either—it should be evaluated based on male factors and previous fertilization outcomes.
For fertility consultation in Kyrgyzstan, please contact your dedicated consultant
/Fertility Consultation /
Dr.Chan
Copy and add: Tulip_EnoChan
Or long press/scan the QR code to add
![]()


Tulip International Fertility Center
Technology aids fertility, fulfilling dreams for countless families

